Global Automated External Defibrillator Market: Trends, Share, Size, Growth, Opportunity and Forecast 2022-2028

Defibrillators are medical devices that defibrillate or stabilise a person's heartbeat when they experience ventricular tachycardia or arrhythmias (an irregular heartbeat) (a heart rhythm disorder). People who have experienced sudden cardiac arrest can be revived using automated external defibrillators (AEDs). People who are suffering from sudden cardiac arrest, a serious heart condition, can be treated with the help of portable, life-saving AEDs. The electrical system of the heart is usually the cause of cardiac arrests. Defibrillators are thus becoming more and more in demand as cardiac disorders like heart attack and stroke become more and more common.

Automated External Defibrillator Market are lightweight, life-saving medical devices used to treat people suffering from sudden cardiac arrest, a condition in which the heart stops beating abruptly and unexpectedly.

A lightweight, portable device called an automated external defibrillator (AED) shocks the heart with electricity through the chest. After a sudden cardiac arrest, the shock may be able to stop an arrhythmia and restore a normal rhythm (SCA).

The Chain of Survival is made stronger by Automated External Defibrillator Market, which is why they are crucial. In cases of sudden cardiac arrest, they can bring the heart rhythm back to normal. More people can respond to a defibrillation emergency thanks to new, portable AEDs.

The Automated External Defibrillator Market is anticipated to grow as a result of rising consumer demand for or adoption of AEDs. For instance, ZOLL MEDICAL announced the introduction of three automated external defibrillators (AED) models in September 2021 in an effort to enter the Thai market. According to this prediction, Thailand would require 10,000 AEDs.

The global market for automated external defibrillators is anticipated to grow as a result of frequent approvals and launches of novel products. For instance, Royal Philips declared in June 2020 that the FDA had approved the HeartStart FR3 and HeartStart FRx automated external defibrillators (AEDs).